SIL1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-1304
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-ELLGSVNSLLKELR corresponding to C-Terminus according to NP_071909.1, NP_001032722.1.
Specificity
Variants (NP_071909.1; NP_001032722.1) encode the same isoform.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for SIL1 Antibody
Western Blot: SIL1 Antibody [NB100-1304]
Western Blot: SIL1 Antibody [NB100-1304] - Analysis of SIL1 in Human Kidney lysate using NB100-1304 at 1 ug/ ml. Primary incubated for 1 hour. Detected by western blot using chemiluminescence.Applications for SIL1 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:8000
Western Blot
1 - 2 ug/ml
Application Notes
WB: Approx. 55-60 kDa band observed in human liver and kidney extracts (predicted MW of 53 kDa band according to NP_071909.1).
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: SIL1
Alternate Names
BAPMarinesco-Sjogren syndrome, BiP-associated protein, MSS, nucleotide exchange factor SIL1, SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae), ULG5
Entrez Gene IDs
64374 (Human)
Gene Symbol
SIL1
UniProt
Additional SIL1 Products
Product Documents for SIL1 Antibody
Product Specific Notices for SIL1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...